Genetics of susceptibility to tuberculosis in humans

Monaldi Archives for Chest Disease - Pulmonary Series

Volumn 61, Issue 2, 2004, Pages 102-111

  Newport, Melanie J ^a   Nejentsev, S ^b  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Association; Gene; HLA; IFN ; IL 12; Linkage; NRAMP1; Tuberculosis

Indexed keywords

BETA 2 MICROGLOBULIN; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 12; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 1; T LYMPHOCYTE RECEPTOR; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR; VITAMIN D RECEPTOR;

ANIMAL MODEL; BACTERIAL IMMUNITY; ENVIRONMENTAL FACTOR; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC IDENTIFICATION; GENETIC SUSCEPTIBILITY; HUMAN; KNOCKOUT MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POPULATION GENETICS; REVIEW; RISK FACTOR; TUBERCULOSIS;

EID: 6344287712     PISSN: 11220643     EISSN: 2465101X     Source Type: Journal    
DOI: 10.4081/monaldi.2004.707     Document Type: Review

References (123)

1. Dye C, Scheele S, Dolin P, V. P, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO global surveillance and monitoring project. JAMA 1999; 282: 677-686.
2. Fine PEM. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1993; 346: 1334-1345.
3. Dye C, Espinal MA, Watt CJ, Mbiaga C, Williams BG. Worldwide incidence of multidrug-resistant tuberculosis. J Infect Dis 2002; 185: 1197-1202.
4. Sorensen TIA, Nielson GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. New Engl J Med 1988; 318: 727-732.
5. Fine PEM. Immunogenetics of susceptibility to leprosy, tuberculosis and leishmania. An epidemiological perspective. Int J Lepr 1981; 49: 437-454.
6. Stead WW, Senner JW, Reddick WT, Lofgren JP. Racial differences in susceptibility to infection by Mycobacterium tuberculosis. N Engl J Med 1990; 322: 422-427.
7. Stead WW. Genetics and resistance to tuberculosis. Ann Intern Med 1992; 116: 937-994.
8. Motulsky AG. Metabolic polymorphisms and the role of infectious diseases in human evolution. Hum Biol 1960 (32): 28-62.
9. Sousa AO, Salem JI, Lee FK, et al. An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazil Amazon. Proc Natl Acad Sci USA 1997; 94: 13227-13232.
10. Kallman FJ, Reisner D. Twin studies on genetic variations in resistance to tuberculosis. J Hered 1943; 34: 293-301.
11. Comstock G. Tuberculosis in twins: a re-analysis of the prophit survey. Am Rev Respir Dis 1978; 117: 621-624.
12. Orme IM. The mouse as a useful model for tuberculosis. Tuberculosis 2003; 83: 112-115.
13. Pfeffer K, Mak TW. Lymphocyte ontogeny and activation in gene targeted mutant mice. Annu Rev Immunol 1994; 12: 367-411.
14. Erb KJ, Kirman J, Delahunt B, Chen W, LeGros G. IL-4, IL-5 and IL-10 are not required for the control of M. bovis-BCG infection in mice. Immunol Cell Biol 1998; 76: 41-46.
15. Laochumroonvorapong P, Wang J, Liu CC, et al. Perforin, a cytotoxic molecule which mediates cell necrosis, is not required for the early control of mycobacterial infection in mice. Infect Immun 1997; 65: 127-132.
16. Kaufmann SH. Immune response to tuberculosis: experimental animal models. Tuberculosis 2003; 83: 107-111.
17. Vidal S, Tremblay ML, Govoni G, et al. The Ity/Lsh/Bcg locus: natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J Exp Med 1995; 182: 655-666.
18. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, et al. Tumor necrosis factor-α is required in the protective immune response against Mycobacteruim tuberculosis in mice. Immunity 1995; 2: 561-572.
19. Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in IFN-γ gene disrupted mice. J Exp Med 1993; 178: 2243-2247.
20. Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon γ in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178: 2249-2254.
21. Kamijo R, Le J, Shapiro D, Havell EA, Huang S, Aguet M, et al. Mice that lack the interferon-gamma receptor have profoundly altered responses to infection with Bacillus Calmette-Guerin and subsequent challenge with lipopolysaccharide. J Exp Med 1993; 178: 1435-40.
22. Flynn JL, Goldstein MM, Treibold KJ, Koller B, Bloom BR. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci USA 1992; 89: 12013-12017.
23. Ladel CH, Dauglat S, Kaufmann SHE. Immune responses to Mycobacterium bovis bacille Calmette Guerin infection in major histocompatibility complex class I- and II deficient mice: contribution of CD4 and CD8 cels to acquired resistance. Eur J Immunol 1995; 25: 377-384.
24. Ladel CH, Hess J, Daugelet S, Mombaerts P, Tonegawa S, Kaufmann SHE. Contribution of α/β and γ/δ T lymphocytes to immunity against Mycobacterium bovis bacillus Calmette Guerin: studies with T cell receptor deficient mutant mice. Eur J Immunol 1995; 25: 838-846.
25. Kamijo R, Harada H, Matsuyama T, et al. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994; 263: 1612-1615.
26. Ladel CH, Blum C, Dreher A, Reifenberg K, Kopf M, Kaufmann SH. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun 1997; 65: 4843-4849.
27. Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin-12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997; 186: 39-45.
28. Scanga CA, Mohan VP, Tanaka K, Alland D, Flynn JL, Chan J. The inducible nitric oxide synthase locus confers protection against aerogenic challenge of both clinical and laboratory strains of Mycobcaterium tuberculosis. Infect Immun 2001; 69: 7711-7717.
29. Abel B, Thieblemont N, Quesniaux VJF, et al. Toll-like receptor 4 expression is required to control chronic Mycobacterium tuberculosis infection in mice. J Immunol 2002; 169: 3155-3162.
30. Newport MJ, Holland SM, Levin M, Casanova J-L. Inherited disorders of the interleukin-12-interferon gamma axis. In: Ochs HD, Smith E, Puck JM, editors. Primary Immunodeficiency Diseases. A Molecular and Genetic Approach. Oxford: Oxford University Press; 2004.
31. Newport MJ. The genetics of nontuberculous mycobacterial infection. Exp Rev Mol Med 2003; http: //www.expertreviews.org/03005908h.htm (28th February 2003).
32. Levin M, Newport MJ, D'Souza S, et al. Familial disseminated atypical mycobacterial infection in early childhood: a human mycobacterial susceptibility gene? Lancet 1995; 345: 79-83.
33. Newport MJ, Huxley CM, Huston S, et al. A mutation in the interferon-gamma receptor gene and susceptibility to mycobacterial infections in man. N Engl J Med 1996; 335: 1941-1949.
34. Jouanguy E, Altare F, Lamhamedi S, et al. Interferon-gamma-receptor deficiency in an infant with fatal bacille Calmette-Guerin infection. N Engl J Med 1996; 335: 1956-1959.
35. Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fischer A. Immunological conditions of children with BCG disseminated infection. Lancet 1995; 346: 581.
36. Casanova J-L, Blanche S, Emile J-F, et al. Idiopathic disseminated bacille Calmette-Guerin infection: a French national retrospective study. Pediatrics 1996; 98: 774-778.
37. Jouanguy E, Lamamedi-Cherradi S, Altare F, et al. Partial interferon-γ receptor 1 deficiency in a child with tuberculoid bacillus Calmette-Guerlin infection and a sibling with clinical tuberculosis. J Clin Invest 1997; 100: 2658-2664.
38. Jouanguy E, Lamhamedi-Cherradi S, Lammas D, et al. A human IFNGRI small deletion hotspot associated with dominant susceptibility to mycobacterial infection. Nat Genet 1999; 21: 370-378.
39. Dorman SE, Holland SM. Mutation in the signal transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. J Clin Invest 1998; 101: 2364-2369.
40. Dupuis S, Dargemont C, Fieschi C, et al. Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation. Science 2001; 293: 300-303.
41. Altare F, Durandy A, Lammas D, et al. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 1998; 280: 1432-1435.
42. de Jong R, Altare F, Haagen I-A, et al. Severe mycobacterial and Salmonella infections in interleukin-12 receptor deficient patients. Science 1998; 280: 1435-1438.
43. Altare F, Lammas D, Revy P, et al. Inherited interleukin 12 deficiency in a child with Bacille Calmette-Guerin and Salmonella enteritidis disseminated infection. J Clin Invest 1998; 102: 2035-2040.
44. Hauser ER, Boehnke M, Guo S-W, Risch N. Affected-sib-pair interval mapping and exclusion for complex genetic traits. Genet Epidemiol 1996; 13: 117-137.
45. Dahlman I, Eaves IA, Kosoy R, et al. Parameters for reliable results in genetic association studies in common disease. Nat Genet 2002; 30: 149-150.
46. Nejentsev S, Gombo Z, Laine AP, et al. Non-class II HLA gene associated with type 1 diabetes maps to the 240-kb region near HLA-B. Diabetes 2000; 49: 2217-2221.
47. Nejentsev S, Reijonen H, Adojaan B, et al. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQ1*0302. Diabetes 1997; 46: 1888-1892.
48. Flynn JL, Chan J. Immunology of tuberculosis. Annu Rev Immunol 2001; 19: 93-129.
49. Lazarevic V, Flynn J. CD8+ T cells in tuberculosis. Am J Respir Crit Care Med 2002; 166: 1116-1121.
50. Selby R, Bernard MJ, Buehler KS, Crumley J, Larsen B, Marshall WH. Tuberculosis associated with HLA-B8, BfS in a Newfoundland community. Tissue Antigens 1978; 11: 403-408.
51. Zervas J, Constantopoulos C, Toubis M, Anagnostopoulos D, Cotsovoulou V. HLA-A and B antigens and pulmonary tuberculosis in Greeks. Br J Dis Chest 1987; 81: 147-149.
52. Khomenko AG, Litvinov VI, Chukanova VP, Pospelov LE. Tuberculosis in patients with various HLA phenotypes. Tubercle 1990; 71: 187-192.
53. Dubaniewicz A, Lewko B, Moszkowska G, Zamorska B, Stepinski J. Molecular subtypes of the HLA-DR antigens in pulmonary tuberculosis. Int J Infect Dis 2000; 4: 129.
54. Dubaniewicz A, Szczerkowska Z, Hoppe A. Molecular subtypes of the HLA-DR antigens in pulmonary sarcoidosis and tuberculosis in the same ethnic group. Mayo Clin Proc 2003; 78: 429-442.
55. Pospelov LE, Matrakshin AG, Chernousova LN, et al. Association of various genetic markers with tuberculosis and other lung diseases in Tuvinian children. Tubercle and Lung Disease 1996; 77: 77-80.
56. Cox RA, Arnold DR, Cook D, Lundberg DI. HLA phenotypes in Mexican Americans with tuberculosis. Am Rev Respir Dis 1982; 126: 653-655.
57. Cox RA, Downs M, Neimes RE, Ognibene AJ, Yamashita TO, Ellner JJ. Immunogenetic analysis of human tuberculosis. J Infect Dis 1988; 158: 1302-1308.
58. Teran-Escandon D, Teran-Ortiz L, Camarena-Olvera A, et al. Human leukocyte antigen-associated susceptibility to pulmonary tuberculosis: molecular analysis of class II alleles by DNA amplification and oligonucleotide hybridization in Mexican patients. Chest 1999; 115: 428-433.
59. Al-Arif LI, Goldstein RA, Affronti LF, Janicki W. HLA-Bw15 and tuberculosis in a North American black population. Am Rev Respir Dis 1979; 120: 1275-1278.
60. Hwang CH, Khan S, Ende N, Mangura BT, Reichman LB, Chou J. The HLA-A, -B, and -DR phenotypes and tuberculosis. Am. J. Respir. Dis. 1985; 132: 382-385.
61. Hafez M, El-Salab SH, El-Shennawy F, Bassiony MR. HLA-antigens and tuberculosis in the Egyptian population. Tubercle 1985; 66: 35-40.
62. Takata H, Sada H, Ozawa S, Sekiguchi S. HLA and mycobacterial infection: increased frequency of B8 in Japanese leprosy. Tissue Antigens 1978; 11: 61-64.
63. Jiang ZF, An JB, Sun YP, Mittal KK, Lee TD. Association of HLA-Bw35 with tuberculosis in the Chinese. Tissue Antigens 1983; 22: 86-88.
64. Hawkins BR, Higgins DA, Chan SL, Lowrie DB, Mitchison DA, Girling DJ. HLA typing in the Hong Kong Chest Service/British Medical Research Council study of factors associated with the breakdown to active tuberculosis of inactive pulmonary lesions. Am Rev Respir Dis 1988; 138: 1616-1621.
65. Goldfeld AE, Delgado JC, Thim S, et al. Association of an HLA-DQ allele with clinical tuberculosis. JAMA 1998; 279: 226-228.
66. Vejbaesya S, Chielakul N, Luangtrakool K, Srinak D, Stephens HA. Associations of HLA class II alleles with pulmonary tuberculosis in Thais. J Immunogenet 2002; 29: 431-434.
67. Bothamley GH, Beck JS, Geziena M, et al. Association of tuberculosis and M. tuberculosis-specific antibody levels with HLA. J Infect Dis 1989; 59: 549-555.
68. Singh SPN, Mehra NK, Dingley HB, Pande JN, Vaidya MC. Human leukocyte antigen (HLA)-linked control of susceptibility to pulmonary tuberculosis and association with HLA-DR types. J Infect Dis 1983; 148: 676-681.
69. Singh SPN, Mehra NK, Dingley HB, Pande JN, Vaidya MC. HLA-A, -B, -C and -DR antigen profile in pulmonary tuberculosis in North India. Tissue Antigens 1983; 21: 384-384.
70. Papiha SS, Wentzel J, Behjati F, Agarwal SS. Human leukocyte antigens and circulating immunoglobulin levels in Indian patients with pulmonary tuberculosis. Tubercle 1985; 66: 25-33.
71. Papiha SS, Singh BN, Lanchbury JS, et al. Association of HLA and other genetic markers in South Indian patients with pulmonary tuberculosis. Tubercle 1987; 68: 158-167.
72. Brahmajothi V, Pitchappan RM, Kakkanaiah VN, et al. Association of pulmonary tuberculosis and HLA in South India. Tubercle 1991; 72: 123-132.
73. Sanjeevi CB, Narayanan PR, Prabakar R, et al. No association or linkage with HLA-DR or -DQ genes in south Indians with pulmonary tuberculosis. Tuber Lung Dis 1992; 73: 280-284.
74. Selvaraj P, Reetha AM, Uma H, et al. Influence of HLA-DR and -DO phenotypes on tuberculin reactive status in pulmonary tuberculosis patients. Tuber Lung Dis 1996; 77: 369-373.
75. Rajalingam R, Mehra NK, Jain RC, Myneedu VP, Pande JN. Polymerase chain reaction-based squence specific oligonucleotide hybridization analysis of HLA class II antigens in pulmonary tuberculosis: relevance to chemotherapy and disease severity. J Infect Dis 1996; 173: 669-676.
76. Ravikumar M, Dheenadhayalan V, Rajaram K, et al. Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in south India. Tuber Lung Dis 1999; 79: 309-317.
77. Gros P, Skamene E, Forget A. Genetic regulation of natural resistance to Mycobacteruim bovis BCG. J Immunol 1981; 127: 2417-2421.
78. Vidal SM, Malo D, Vogan K, Skamene E, Gros P. Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg. Cell 1993; 73: 469-485.
79. Liu J, Fujiwara TM, Buu NT, et al. Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet 1995; 56: 845-853.
80. Bellamy R, Ruwende C, Corrah T, McAdam KPW, Whittle HC, Hill AVS. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338: 640-644.
81. Cervino AC, Lakiss S, Sow O, Hill AV. Allelic association between the NRAMP1 gene and susceptibility to tuberculosis in Guinea-Conakry. Ann Hum Genet 2000; 64: 507-512.
82. Searle S, Blackwell JM. Evidence for a functional repeat polymorphism in the promoter region of human NRAMP1 that correlates with infectious versus autoimmune disease susceptibility. J Med Genet 1999; 36: 295-299.
83. Awomoyi AA, Marchant A, Howson JMM, McAdam KPWJ, Blackwell JM, Newport MJ. Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1) and susceptibility to tuberculosis. J Inject Dis 2002; 186: 1808-1814.
84. Greenwood CMT, Fujiwara TM, Boothroyd LJ, et al. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large Aboriginal Canadian family. Am J Hum Genet 2000; 67: 405-416.
85. El Baghdadi J, Remus N, Benslimane A, et al. Variants of the human NRAMP1 gene and susceptibility to tuberculosis in Morocco. Int J Tuberc Lung Dis 2003; 7: 599-602.
86. Gao PS, Fujishima S, Mao XQ, et al. Genetic variants of NRAMP1 and active tuberculosis in Japanese populations. International Tuberculosis Genetics Team. Clin Genet 2000; 58: 74-76.
87. Ma X, Dou S, Wright JA, et al. 5′ dinucleotide repeat polymorphism of NRAMP1 and susceptibility to tuberculosis among Caucasian patients in Houston, Texas. Int J Tuberc Lung Dis 2002; 6: 818-823.
88. Ryu S, Park YK, Bai GH, Kim SJ, Park SN, Kang S. 3′ UTR polymorphisms in the NRAMP1 gene are associated with susceptibility to tuberculosis in Koreans. Int J Tuberc Lung Dis 2000; 4: 577-580.
89. Delgado JC, Baena A, Thim S, Goldfeld AE. Ethnic-specific genetic associations with pulmonary tuberculosis. J Infect Dis 2002; 186: 1463-1468.
90. Liaw YS, Tsai-Wu JJ, Wu CH, et al. Variations in the NRAMP1 gene and susceptibility of tuberculosis in Taiwanese. Int J Tuberc Lung Dis 2002; 6: 454-460.
91. Kim JH, Lee SY, Sin C, et al. NRAMP1 genetic polymorphisms as a risk factor of tuberculous pleurisy. Int J Tuberc Lung Dis 2003; 7: 370-375.
92. Abe T, Iinuma Y, Ando M, et al. NRAMP1 polymorphisms, susceptibility and clinical features of tuberculosis. J Infect 2003; 46: 215-220.
93. Soborg C, Andersen AB, Madsen HO, Kok-Jensen A, Skinhoj P, Garred P. Natural resistance-associated macrophage protein 1 polymorphisms are associated with microscopy-positive tuberculosis. J Infect Dis 2002; 186: 517-521.
94. Strachan DP, Powell KJ, Thaker A, Millard FJC, Maxwell JD. Vegetarian diet as a risk factor for tuebrculosis in immigrnat south London Asians. Thorax 1995; 50: 175-180.
95. Davies PDO, Brown RC, Woodhead JS. Serum concentrations of vitamin D metabolites in untreated tuberculosis. Thorax 1985; 40: 187-190.
96. Wilkinson RJ, Llewelyn M, Toozi Z, et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. Lancet 2000; 355: 618-621.
97. Grange JM, Davies PDO, Brown RC, Woodhead JS, Kardjito T. A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis. Tubercle 1985; 66: 187-191.
98. Rook GAW, Steele J, Fraher L, et al. Vitamin D3, gamma-interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986; 57: 159-163.
99. Rockett KA, Brookes R, Udalove I, Vidal V, Hill AVS, Kwiatkowski D. 1,25-dihydroxyvitamin D induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line. Infect Immun 1998; 66: 5314-5321.
100. Bellamy R, Ruwende C, Corrah T, et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis 1999; 179: 721-724.
101. Selvaraj P, Narayanan PR, Reetha AM. Association of vitamin D receptor genotypes with the susceptibility to pulmonary tuberculosis in female patients and resistance in female contacts. Indian J Med Res 2000; 111: 172-179.
102. Ottenhoff THM, Kumararatne D, Casanova J-L. Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria. Immunol Today 1998; 19: 491-494.
103. Dupuis S, Doffinger R, Picard C, et al. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev 2000; 178: 129-137.
104. Lammas DA, Casanova J-L, Kumararatne DS. Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-γ) pathway. Clin Exp Immunol 2000; 121: 417-425.
105. Lopez-Maderuelo D, Arnalich F, Serantes R, et al. Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis. Am J Respir Crit Care Med 2003; 167: 970-975.
106. Rossouw M, Nel NJ, Cooke GS, van Helden PD, Hoal EG. Association between tuberculosis and a polymorphic NFkappaB binding site in the interferon gamma gene. Lancet 2003; 361: 1871-1872.
107. Lio D, Marino V, Serauto A, et al. Genotype frequencies of the +874T>A single nucleotide polymorphism in the first intron of the interferon-g gene in a sample of Sicilian patients affected by tuberculosis. Eur J Immunogenet 2003; 29: 371-374.
108. Fraser DA, Bulat-Kardum L, Knezevic J, et al. Interferon-γ receptor-1 gene polymorphism in tuberculosis patients from Croatia. Scand J Immunol 2003; 57: 480-484.
109. Newport MJ, Awomoyi AA, Blackwell JM. Polymorphism in the interferon-gamma receptor-1 gene and susceptibility to pulmonary tuberculosis in The Gambia. Scand J Immunol 2003; in press.
110. Awomoyi AA, Neientsev S, Richardson A, et al. No association between interferon-gamma receptor-1 gene polymorphism and pulmonary tuberculosis in a Gambian population sample. Thorax 2004; 59: 291-4.
111. Akahoshi M, Nakashima H, Miyake K, et al. Influence of interleukin-12 receptor β1 polymorphisms on tuberculosis. Hum Genet 2003; 112: 237-243.
112. Wilkinson RJ, Patel P, Llewelyn M, et al. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1 beta on tuberculosis. J Exp Med 1999; 189: 1863-1874.
113. Hoal-van Helden EG, Epstein J, Victor TC, et al. Mannose-binding protein B allele confers protection against tuberculous meningitis. Pediatr Res 1999; 45: 459-464.
114. Soborg C, Madsen HO, Andersen AB, Lillebaek T, Kok-Jensen A, Garred P. Mannose-binding lectin polymorphisms in clinical tuberculosis. J Infect Dis 2003; 188: 777-782.
115. Ma X, Reich RA, Wright JA, et al. Association between interleukin-8 gene alleles and human susceptibility to tuberculosis disease. J Infect Dis 2003; 188: 349-355.
116. Li CM, Campbell SJ, Kumararatne DS, et al. Association of a polymorphism in the P2X7 gene with tuberculosis in a Gambian population. J Inject Dis 2002; 186: 1458-1462.
117. Bellamy R, Ruwende C, McAdam KPWJ, et al. Mannose binding protein deficiency is not associated with malaria, hepatitis B carriage nor tuberculosis in Africans. Q J Med 1998; 91: 13-18.
118. Bellamy R, Ruwende C, Corrah T. Assessment of the interleukin 1 gene cluster and other candidate gene polymorphisms in host susceptibility to tuberculosis. Tubercle Lung Dis 1998; 79: 83-89.
119. Colhoun HM, McKeigue PM, Davey Smitth G. Problems of reporting genetic association studies with complex outcomes. Lancet 2003; 361: 865-872.
120. Bellamy R, Beyers N, McAdam KPWJ, et al. Genetic susceptibility to tuberculosis in Africans: a genome-wide scan. Proc Natl Acad Sci USA 2000; 97: 8005-8009.
121. Cervino ACL, Lakiss S, Sow O, et al. Fine mapping of a putative tuberculosis-susceptibility locus on chromosome 15q11-13 in African families. Hum Mol Genet 2002; 11: 1599-1603.
122. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
123. Cordell HJ. Sample size requirements to control for stochastic variation in magnitude and location of allele sharing linkage statistics in affected sibling pairs. Ann Hum Genet 2001; 65: 491-502.